162 related articles for article (PubMed ID: 17089002)
1. Genetic analysis of peroxisome proliferator-activated receptor gamma1 splice variants in human colorectal cell lines.
Fiatte C; Huin C; Bertin I; Lesuffleur T; Pluvinet A; Touche N; Plénat F; Dauça M; Domenjoud L; Schohn H
Int J Oncol; 2006 Dec; 29(6):1601-10. PubMed ID: 17089002
[TBL] [Abstract][Full Text] [Related]
2. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
5. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
Coyle AT; Kinsella BT
Biochem Pharmacol; 2006 Apr; 71(9):1308-23. PubMed ID: 16499875
[TBL] [Abstract][Full Text] [Related]
6. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
Komatsu Y; Ito I; Wayama M; Fujimura A; Akaogi K; Machida H; Nakajima Y; Kuroda T; Ohmori K; Murayama A; Kimura K; Yanagisawa J
Biochem Biophys Res Commun; 2008 May; 370(1):145-8. PubMed ID: 18355447
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone and 9cis,11trans,13trans-conjugated linolenic acid: comparison of their antiproliferative and apoptosis-inducing effects on different colon cancer cell lines.
Yasui Y; Hosokawa M; Kohno H; Tanaka T; Miyashita K
Chemotherapy; 2006; 52(5):220-5. PubMed ID: 16899971
[TBL] [Abstract][Full Text] [Related]
8. Pivotal role of peroxisome proliferator-activated receptor gamma (PPARgamma) in regulation of erythroid progenitor cell proliferation and differentiation.
Nagasawa E; Abe Y; Nishimura J; Yanase T; Nawata H; Muta K
Exp Hematol; 2005 Aug; 33(8):857-64. PubMed ID: 16038777
[TBL] [Abstract][Full Text] [Related]
9. Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression.
Gijsbers L; Man HY; Kloet SK; de Haan LH; Keijer J; Rietjens IM; van der Burg B; Aarts JM
Anal Biochem; 2011 Jul; 414(1):77-83. PubMed ID: 21354099
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma overexpression suppresses proliferation of human colon cancer cells.
Tsukahara T; Haniu H
Biochem Biophys Res Commun; 2012 Aug; 424(3):524-9. PubMed ID: 22771328
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma-independent suppression of androgen receptor expression by troglitazone mechanism and pharmacologic exploitation.
Yang CC; Wang YC; Wei S; Lin LF; Chen CS; Lee CC; Lin CC; Chen CS
Cancer Res; 2007 Apr; 67(7):3229-38. PubMed ID: 17409431
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC
Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067
[TBL] [Abstract][Full Text] [Related]
13. Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARgamma.
Au-Yeung KK; Liu PL; Chan C; Wu WY; Lee SS; Ko JK
Cancer Invest; 2008 Aug; 26(7):708-17. PubMed ID: 18608213
[TBL] [Abstract][Full Text] [Related]
14. Identification of a truncated alternative splicing variant of human PPARgamma1 that exhibits dominant negative activity.
Kim HJ; Woo IS; Kang ES; Eun SY; Kim HJ; Lee JH; Chang KC; Kim JH; Seo HG
Biochem Biophys Res Commun; 2006 Sep; 347(3):698-706. PubMed ID: 16842753
[TBL] [Abstract][Full Text] [Related]
15. Evidence for differential effects of glucose and cycloheximide on mRNA levels of peroxisome proliferator-activated receptor- (PPAR-) machinery members: Superinduction of PPAR-gamma1 and -gamma2 mRNAs.
Rypka M; Veselý J
Acta Biochim Pol; 2010; 57(2):209-15. PubMed ID: 20563322
[TBL] [Abstract][Full Text] [Related]
16. The PPAR(gamma) K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment.
Bouancheau D; Buecher B; Jarry A; Simon B; Masson D; Cassagnau E; Hamelin R; Laboisse CL; Bézieau S; Denis MG
Cancer Lett; 2005 Jun; 224(1):111-6. PubMed ID: 15911106
[TBL] [Abstract][Full Text] [Related]
17. Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.
Ulrich S; Wächtershäuser A; Loitsch S; von Knethen A; Brüne B; Stein J
Exp Cell Res; 2005 Oct; 310(1):196-204. PubMed ID: 16112107
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines.
Park JW; Zarnegar R; Kanauchi H; Wong MG; Hyun WC; Ginzinger DG; Lobo M; Cotter P; Duh QY; Clark OH
Thyroid; 2005 Mar; 15(3):222-31. PubMed ID: 15785241
[TBL] [Abstract][Full Text] [Related]
19. Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability.
Bruedigam C; Koedam M; Chiba H; Eijken M; van Leeuwen JP
FEBS Lett; 2008 May; 582(11):1618-24. PubMed ID: 18435931
[TBL] [Abstract][Full Text] [Related]
20. Expression of PPARgamma is reduced by medium supplementation with L-glutamine in human colorectal Caco-2 cells.
Fiatte C; Huin C; Collet P; Plénat F; Dauça M; Schohn H
Int J Mol Med; 2008 Dec; 22(6):825-32. PubMed ID: 19020782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
